Abbott COO Succession: Leiden Leaves, Gonzalez Takes Over Pharma Group

Abbott Pharmaceutical Products Group President & COO Jeffrey Leiden's experience overseeing the Knoll acquisition could make the exec a particularly attractive candidate in the current climate of increasing M&A activity